ADMINE(Imatinib mesylate)
Therapeutic class: kinase inhibitor
- Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
- Ph+ CML In Blast Crisis (BC), Accelerated Phase (AP) Or Chronic Phase (CP) After Interferon-Alpha (IFN) Therapy.
- Adult & Paediatric patients with Ph+ Acute Lymphoblastic Leukemia (ALL).
- Kit+ Gastrointestinal Stromal Tumors (GIST)
- Adjuvant Treatment Of GIST
- Dermatofibrosarcoma Protuberans (DFSP)
- Hypereosinophilic Syndrome (HES) And/Or Chronic Eosinophilic Leukemia (CEL)
- Aggressive Systemic Mastocytosis (ASM)
100mg & 400mg Tablets
100 mg:-
A strip of 10 tablets400 mg:-
A strip of 10 tablets- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
